$REGN,...Regeneron Pharmaceuticals misses by $0.05, misses on revenue Regeneron Pharmaceuticals (NASDAQ:REGN): Q3 EPS of $2.52 misses by $0.05. Revenue of $726M (+21.6% Y/Y) misses by $7.04M.